Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BUZELLO, W.
Right arrow Articles by HUTTARSCH, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BUZELLO, W.
Right arrow Articles by HUTTARSCH, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1988, Vol. 60, No. 2 228-231
© 1988 The Board of Management and Trustees of the British Journal of Anaesthesia


case-report

MUSCLE RELAXATION IN PATIENTS WITH DUCHENNE'S MUSCULAR DYSTROPHY

Use of Vecuronium in Two Patients

W. BUZELLO, M.D. and H. HUTTARSCH, M.D.

University Department of Anaesthesiology, Joseph-Stelzmann-Str 9, D-5000 Koeln 41, Federal Republic of Germany

Cumulative 50% and 90% neuromuscular blocking doses of vecuronium were determined in two 4-yr-old boys with Duchenne's muscular dystrophy. Vecuronium 20 µg kg–1 was required for 50% twitch depression in both patients. The 90% blocking doses were 43 and 57 µg kg–1. Although these data do not indicate a greater than normal sensitivity to vecuronium, the recovery time (75–25% block) of twitch tension was three to almost six times as long as in normal children. The evoked compound EMG, additionally recorded in one patient, reflected almost the same dose-response relationship as twitch tension, yet the EMG recovered faster than the twitch. The present findings do not exclude an increased sensitivity to neuromuscular blocking drugs in a larger population of patients with muscular dystrophy. Thus, the titration of the individual neuromuscular blocking dose with the aid of a nerve stimulator is mandatory. During a previous anaesthetic, cardiac arrest and acute rhabdomyolysis had occurred in one patient. The substitution of suxamethonium by vecuronium, or probably any other non-depolarizing myoneural blocking drug of intermediate or short duration of action, may help to avoid this complication.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Schmidt, T. Muenster, S. Wick, J. Forst, and H. J. Schmitt
Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy
Br. J. Anaesth., December 1, 2005; 95(6): 769 - 772.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. A. Frankowski, J. O. Johnson, and J. D. Tobias
Rapacuronium Administration to Two Children with Duchenne's Muscular Dystrophy
Anesth. Analg., July 1, 2000; 91(1): 27 - 28.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.